Transdermal delivery systems comprising bupivacaine

Details for Australian Patent Application No. 2007325918 (hide)

Owner Durect Corporation

Inventors Song, Xiao Ping; Kwon, Sung Yun; Yum II, Su; Brown, James E.

Agent Shelston IP

Pub. Number AU-A-2007325918

PCT Pub. Number WO2008/066642

Priority 60/936,866 22.06.07 US; 60/856,656 03.11.06 US

Filing date 29 October 2007

Wipo publication date 5 June 2008

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

24 September 2009 Section 223 Application Allowed

  Durect Corporation The time in which to enter the National Phase has been extended to 03 Aug 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/066642 Priority application(s): WO2008/066642

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325931-Assessment of oocyte competence

2007325907-Methods of disrupting quorum sensing to affect microbial population cell density